Table 10.
Group | Hepatocyte death | Inflammatory cell infiltration | Fibrosis | Combined score |
---|---|---|---|---|
Normal |
0.5 ± 0.3 |
0.3 ± 0.3 |
0.5 ± 0.1 |
0.5 ± 0.3 |
Shamed |
0.8 ± 0.3 |
0.7 ± 0.4 |
0.5 ± 0.3 |
0.8 ± 0.3 |
Model |
4.7 ± 0.8△△ |
4.7 ± 0.4△△ |
5.5 ± 0.7△△ |
4.8 ± 0.6△△ |
Sylimarin |
3.5 ± 0.3* |
4.4 ± 0.9 |
4.5 ± 0.6 |
4.2 ± 0.5 |
Berberine |
2.4 ± 0.5** |
2.3 ± 0.7** |
2.7 ± 0.7** |
2.5 ± 0.6** |
CRAE |
2.7 ± 0.4** |
3.4 ± 0.9* |
3.3 ± 0.3** |
3.0 ± 0.3** |
Bear Bile |
3.9 ± 0.1 |
3.5 ± 0.4** |
3.3 ± 0.6** |
3.8 ± 0.4* |
TUDCA | 2.8 ± 0.3** | 3.7 ± 0.2** | 3.6 ± 0.2** | 3.4 ± 0.2** |
△p < 0.05 when compared with normal group; △△p < 0.01 when compared with normal group; *p < 0.05 when compared with model group; **p < 0.01 when compared with model group.